The article discusses genome sequencing to resolve the genetics of disease and the ongoing development of low-cost methods of doing so. The article notes research being conducted on the use of so-called DNA transistors to develop such methods at the companies International Business Machines (IBM) and Roche.
© 2001-2024 Fundación Dialnet · Todos los derechos reservados